Cargando…
Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines
Melphalan flufenamide (hereinafter referred to as “melflufen”) is a peptide‐conjugated drug currently in phase 3 trials for the treatment of relapsed or refractory multiple myeloma. Due to its lipophilic nature, it readily enters cells, where it is converted to the known alkylator melphalan leading...
Autores principales: | Schepsky, Alexander, Traustadottir, Gunnhildur Asta, Joelsson, Jon Petur, Ingthorsson, Sævar, Kricker, Jennifer, Bergthorsson, Jon Thor, Asbjarnarson, Arni, Gudjonsson, Thorkell, Nupponen, Nina, Slipicevic, Ana, Lehmann, Fredrik, Gudjonsson, Thorarinn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520280/ https://www.ncbi.nlm.nih.gov/pubmed/32717133 http://dx.doi.org/10.1002/cam4.3300 |
Ejemplares similares
-
Cellular Plasticity and Heterotypic Interactions during Breast Morphogenesis and Cancer Initiation
por: Ingthorsson, Saevar, et al.
Publicado: (2022) -
Ventilator-induced lung-injury in mouse models: Is there a trap?
por: Joelsson, Jon Petur, et al.
Publicado: (2021) -
Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model
por: Joelsson, Jon Petur, et al.
Publicado: (2022) -
Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression
por: Ingthorsson, Saevar, et al.
Publicado: (2016) -
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)